Hospital survival following pediatric HSCT: changes in complications, ICU therapies and outcomes over 10 years
IntroductionHematopoietic stem cell transplantation (HSCT) is an increasingly utilized therapy for malignant and non-malignant pediatric diseases. HSCT complications, including infection, organ dysfunction, and graft-versus-host-disease (GVHD) often require intensive care unit (ICU) therapies and ar...
Saved in:
Main Authors: | Taylor L. Olson (Author), Murray M. Pollack (Author), Blachy J. Dávila Saldaña (Author), Anita K. Patel (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Autoimmune complication post HSCT in a case of MDS with monosomy 7
by: Zainab M. Golwala, et al.
Published: (2017) -
Prevention and management of human cytomegalovirus in pediatric HSCT recipients: A review
by: Lisa Hiskey, et al.
Published: (2022) -
The criticality Index-mortality: A dynamic machine learning prediction algorithm for mortality prediction in children cared for in an ICU
by: Anita K Patel, et al.
Published: (2022) -
The effect of decitabine-combined minimally myelosuppressive regimen bridged allo-HSCT on the outcomes of pediatric MDS from 10 years' experience of a single center
by: Junyan Gao, et al.
Published: (2022) -
Allogeneic HSCT in Adolescents and Young Adults With Primary Immunodeficiencies
by: Emma C. Morris, et al.
Published: (2019)